Madrigal Pharmaceuticals, Inc.
MDGL Healthcare
₹ 518.76
12.30%
Live Market Data
Market Cap₹ 1,190 Cr.
Current Price₹ 518.76
High / Low₹615 / 265
Stock P/E0.0
Book Value₹26.4
Dividend Yield0.00 %
ROCE-0.2 %
ROE-0.4 %
About Company
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.
Industry Segment
Biotechnology
Price Chart
Loading Chart...
Technical Analysis
Technical Outlook
Short TermBullish
Mid TermBullish
Long TermNeutral
Resistance₹496.98
Support₹314.02
Valuation Check
Fair Value Assessment
Overvalued
Research Reports
Daily – Vickers Top Buyers & Sellers for 01/27/2026
Daily – Vickers Top Buyers & Sellers for 01/21/2026
Quarterly Results
| Particulars | Dec 25 | Sept 25 | Jun 25 | Mar 25 | Dec 24 |
|---|---|---|---|---|---|
| Total Revenue (Cr) | 32.11 | 28.73 | 21.28 | 13.72 | 10.33 |
| Net Income (Cr) | -5.86 | -11.42 | -4.23 | -7.32 | -5.94 |
| EPS (₹) | -2.57 | -5.08 | -1.9 | -3.32 | -2.71 |
Annual Profit & Loss
| Particulars | 2025 | 2024 | 2023 | 2022 | 1970 |
|---|---|---|---|---|---|
| Total Revenue (Cr) | 95.84 | 18.01 | 0 | 0 | 0 |
| Operating Exp (Cr) | 120.24 | 67.18 | 38.05 | 29.36 | 0 |
| Net Income (Cr) | -28.83 | -46.59 | -37.36 | -29.54 | 0 |
| EPS (₹) | -12.85 | -21.9 | -19.99 | -17.23 | 0 |
Balance Sheet
| Particulars | Dec 25 | Sept 25 | Jun 25 | Mar 25 | Dec 24 |
|---|---|---|---|---|---|
| Total Assets (Cr) | 125.96 | 136.25 | 101.54 | 99.66 | 104.22 |
| Total Liabilities (Cr) | 65.69 | 73.67 | 31.94 | 28.6 | 28.79 |
| Total Equity (Cr) | 60.27 | 62.57 | 69.6 | 71.06 | 75.44 |
Key Ratios Fundamentals
Valuation
P/E Ratio (TTM)
-Forward P/E
40.55PEG Ratio
-Price / Book
19.66EV / EBITDA
-33.36Profitability
ROE
-42.49%ROA
-16.30%Profit Margin
-30.08%Operating Margin
-18.57%Liquidity & Debt
Current Ratio
4.01Quick Ratio
3.60Debt / Equity
57.68Total Cash (Cr)
98.36Price Statistics
Beta
-0.9652W High
615.0052W Low
265.00Dividend Yield
-Pattern Unavailable
Detailed shareholding breakdown is not currently provided by the exchange.